Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| RVMD - Revolution Medicines | 7.54% | Reduce −6.7% | 13,604,796 | $97.25 | $1.3B | −978,000 | +$162M |
| AMZN - Amazon | 5.01% | Reduce −6.3% | 4,218,394 | $208.27 | $879M | −281,500 | −$160M |
| MSFT - Microsoft | 4.95% | Add +5.9% | 2,344,779 | $370.17 | $868M | +130,700 | −$203M |
| AON - AON PLC · CL A | 4.62% | Reduce −5.7% | 2,512,638 | $322.78 | $811M | −152,600 | −$129M |
| BBIO - Bridgebio Pharma | 3.96% | Add +4.1% | 9,365,463 | $74.26 | $695M | +367,000 | +$7M |
| PTGX - Protagonist Therapeutics | 3.81% | Add +3.3% | 6,348,906 | $105.40 | $669M | +204,900 | +$133M |
| NTRA - Natera | 3.66% | Reduce −18.1% | 3,207,366 | $199.99 | $641M | −707,000 | −$255M |
| EXEL - Exelixis | 3.21% | Reduce −16.5% | 13,111,010 | $42.89 | $562M | −2,598,490 | −$126M |
| AVGO - Broadcom | 3.14% | Add +99.4% | 1,779,500 | $309.51 | $551M | +887,100 | +$242M |
| UNH - Unitedhealth Group | 2.81% | Add +13.9% | 1,821,706 | $270.59 | $493M | +222,800 | −$35M |
| SNPS - Synopsys | 2.74% | Add +21.4% | 1,213,300 | $396.48 | $481M | +214,100 | +$12M |
| BSX - Boston Scientific | 2.67% | Add +0.4% | 7,470,684 | $62.75 | $469M | +31,120 | −$241M |
| TMO - Thermo Fisher Scientific | 2.47% | Add +38.7% | 881,485 | $491.53 | $433M | +245,800 | +$65M |
| KKR — | 2.46% | Add +131.5% | 4,671,800 | $92.50 | $432M | +2,654,100 | +$175M |
| LNTH - Lantheus | 2.41% | Add +2.9% | 5,583,479 | $75.85 | $424M | +156,000 | +$62M |
| WAB - Wabtec | 2.29% | Reduce −35.0% | 1,609,403 | $249.91 | $402M | −866,600 | −$126M |
| SCHW - Schwab Charles | 2.12% | Add +18.4% | 3,955,657 | $93.98 | $372M | +616,000 | +$38M |
| LQDA - Liquidia | 1.86% | Hold | 8,656,038 | $37.74 | $327M | — | — |
| CRNX — | 1.73% | Add +20.3% | 8,338,098 | $36.32 | $303M | +1,405,000 | −$20M |
| GOOG - Alphabet · CL C | 1.63% | Add +26.6% | 996,231 | $286.86 | $286M | +209,191 | +$39M |
| ROIV - Roivant Sciences | 1.53% | Add +26048.6% | 9,675,000 | $27.70 | $268M | +9,638,000 | +$267M |
| V - VISA · CL A | 1.45% | Add +20.8% | 840,710 | $302.24 | $254M | +144,800 | +$10M |
| ARMK - Aramark | 1.42% | Reduce −34.4% | 6,135,431 | $40.54 | $249M | −3,221,615 | −$96M |
| BEAM - Beam Therapeutics | 1.38% | Add +0.7% | 10,134,696 | $23.83 | $242M | +71,585 | −$37M |
| DIS - Disney Walt | 1.32% | Reduce −41.8% | 2,401,591 | $96.38 | $231M | −1,724,400 | −$238M |
| MA - Mastercard · CL A | 1.24% | Add +152.0% | 435,071 | $499.66 | $217M | +262,400 | +$119M |
| MCK - Mckesson | 1.16% | Reduce −21.6% | 234,300 | $865.36 | $203M | −64,600 | −$42M |
| AGIO - Agios Pharmaceuticals | 1.10% | Add +10.2% | 5,684,000 | $33.83 | $192M | +524,495 | +$52M |
| CNTA - Centessa Pharmaceuticals | 1.09% | Reduce −10.6% | 4,809,000 | $39.72 | $191M | −568,068 | +$57M |
| TNGX - Tango Therapeutics | 1.08% | Reduce −30.3% | 9,097,411 | $20.92 | $190M | −3,964,000 | +$75M |
| GRAL - Grail | 0.96% | Add +38.9% | 3,253,684 | $51.68 | $168M | +911,000 | −$32M |
| TYRA - Tyra Biosciences | 0.78% | Add +73.3% | 3,580,818 | $38.30 | $137M | +1,514,000 | +$83M |
| THC - Tenet Healthcare | 0.49% | Add +21.5% | 452,153 | $188.71 | $85M | +80,000 | +$11M |
| CAH - Cardinal Health | 0.44% | Reduce −36.1% | 368,000 | $211.31 | $78M | −208,000 | −$41M |
| PCVX - Vaxcyte | 0.42% | Add +25120.0% | 1,261,000 | $58.11 | $73M | +1,256,000 | +$73M |
| DNTH - Dianthus Therapeutics | 0.40% | New | 836,000 | $83.92 | $70M | +836,000 | +$70M |
| BTSG - Brightspring Health Svcs | 0.39% | Add +7250.0% | 1,617,000 | $42.61 | $69M | +1,595,000 | +$68M |
| TWST - Twist Bioscience | 0.39% | Add +18562.1% | 1,427,650 | $47.52 | $68M | +1,420,000 | +$68M |
| BIDU - Baidu | 0.28% | Add +40.8% | 443,785 | $111.42 | $49M | +128,485 | +$8M |
| CGON - Cg Oncology | 0.26% | Add +8325.0% | 674,000 | $67.68 | $46M | +666,000 | +$45M |
| AZN - Astrazeneca | 0.25% | New | 226,499 | $197.22 | $45M | +226,499 | +$45M |
| MRK - Merck & | 0.25% | New | 361,000 | $120.29 | $43M | +361,000 | +$43M |
| ACHC — | 0.23% | New | 1,736,800 | $23.39 | $41M | +1,736,800 | +$41M |
| WELL - Welltower | 0.23% | Reduce −41.7% | 200,000 | $197.71 | $40M | −143,000 | −$24M |
| IMVT - Immunovant | 0.22% | Add +12783.3% | 1,546,000 | $24.84 | $38M | +1,534,000 | +$38M |
| ENTA - Enanta Pharmaceuticals | 0.21% | Add +3.6% | 2,871,862 | $12.63 | $36M | +99,600 | −$7M |
| JNJ - Johnson & Johnson | 0.21% | New | 148,000 | $244.44 | $36M | +148,000 | +$36M |
| BBNX - Beta Bionics | 0.21% | Reduce −16.4% | 3,607,920 | $10.02 | $36M | −706,000 | −$95M |
| ASMB - Assembly Biosciences | 0.19% | Hold | 1,227,590 | $27.75 | $34M | — | — |
| JOYY — | 0.19% | Hold | 578,200 | $58.39 | $34M | — | — |
| NTES - Netease | 0.19% | New | 291,219 | $111.94 | $33M | +291,219 | +$33M |
| NVO - Novo-Nordisk A S | 0.16% | New | 782,000 | $36.75 | $29M | +782,000 | +$29M |
| BITW - Bitwise 10 Crypto Index ETF | 0.15% | Reduce −82.2% | 603,000 | $44.61 | $27M | −2,782,500 | −$172M |
| PCSC - Perceptive Cap Solutions · CL A | 0.14% | Hold | 2,250,000 | $10.97 | $25M | — | — |
| RPRX - Royalty Pharma · CLASS A | 0.13% | New | 493,000 | $47.97 | $24M | +493,000 | +$24M |
| NERV - Minerva Neurosciences | 0.08% | Hold | 2,365,000 | $6.02 | $14M | — | — |
| CECO - Ceco Environmental | 0.08% | New | 234,000 | $59.58 | $14M | +234,000 | +$14M |
| AVTX - Avalo Therapeutics | 0.08% | New | 916,000 | $14.93 | $14M | +916,000 | +$14M |
| GDS — | 0.07% | New | 292,000 | $40.29 | $12M | +292,000 | +$12M |
| MAZE - Maze Therapeutics | 0.06% | New | 373,000 | $29.85 | $11M | +373,000 | +$11M |
| TEVA - Teva Pharmaceutical Inds | 0.06% | Add +785.0% | 354,000 | $30.12 | $11M | +314,000 | +$9M |
| FORM - Formfactor | 0.03% | New | 56,500 | $96.99 | $5M | +56,500 | +$5M |
| MTZ - Mastec | 0.03% | New | 17,000 | $321.74 | $5M | +17,000 | +$5M |
| ENTG - Entegris | 0.03% | New | 45,500 | $117.24 | $5M | +45,500 | +$5M |
| C - Citigroup | 0.03% | New | 47,000 | $113.41 | $5M | +47,000 | +$5M |
| VNET - VNET Group | 0.03% | Reduce −90.1% | 623,347 | $8.39 | $5M | −5,662,039 | −$48M |
| H - Hyatt Hotels · CL A | 0.03% | New | 36,000 | $143.79 | $5M | +36,000 | +$5M |
| WST - Western Alliance Bancorp | 0.03% | New | 73,000 | $70.85 | $5M | +73,000 | +$5M |
| TKR - Timken | 0.03% | New | 51,000 | $100.57 | $5M | +51,000 | +$5M |
| FLEX - Flextronics Intl | 0.03% | New | 78,000 | $65.46 | $5M | +78,000 | +$5M |
| SPGI - S&P Global | 0.03% | New | 12,000 | $425.34 | $5M | +12,000 | +$5M |
| LFUS - Littelfuse | 0.03% | New | 15,000 | $339.35 | $5M | +15,000 | +$5M |
| PIPR - Piper Sandler Companies | 0.03% | New | 66,000 | $76.55 | $5M | +66,000 | +$5M |
| AIR - AAR | 0.03% | New | 46,000 | $109.46 | $5M | +46,000 | +$5M |
| RIO - Rio Tinto | 0.03% | New | 53,800 | $93.29 | $5M | +53,800 | +$5M |
| GTX - Garrett Motion | 0.03% | New | 275,000 | $18.17 | $5M | +275,000 | +$5M |
| ROL - Rollins | 0.03% | New | 93,000 | $53.41 | $5M | +93,000 | +$5M |
| AFRM - Affirm · CL A | 0.03% | New | 108,000 | $45.82 | $5M | +108,000 | +$5M |
| INTR - Inter & · CLASS A | 0.03% | New | 614,500 | $7.96 | $5M | +614,500 | +$5M |
| CMI - Cummins | 0.03% | New | 9,000 | $538.02 | $5M | +9,000 | +$5M |
| FISV - Fiserv | 0.03% | New | 86,000 | $55.80 | $5M | +86,000 | +$5M |
| VRT - Vertiv · CL A | 0.03% | New | 19,000 | $250.58 | $5M | +19,000 | +$5M |
| AMKR - Amkor Technology | 0.03% | Reduce −77.6% | 104,000 | $45.03 | $5M | −360,000 | −$14M |
| RNA - Atrium Therapeutics | 0.03% | New | 349,360 | $13.37 | $5M | +349,360 | +$5M |
| GFS - Globalfoundries | 0.03% | New | 105,000 | $44.48 | $5M | +105,000 | +$5M |
| MOH - Molina Healthcare | 0.03% | New | 35,000 | $133.30 | $5M | +35,000 | +$5M |
| IRD - Opus Genetics | 0.03% | New | 1,000,000 | $4.55 | $5M | +1,000,000 | +$5M |
| TENB - Tenable | 0.03% | New | 265,000 | $16.92 | $4M | +265,000 | +$4M |
| PRME - Prime Medicine | 0.02% | Hold | 1,240,843 | $3.48 | $4M | — | — |
| NOW - Servicenow | 0.02% | New | 41,000 | $104.55 | $4M | +41,000 | +$4M |
| SMC - Summit Midstream | 0.01% | Hold | 58,214 | $30.24 | $2M | — | — |
| MDGL - Madrigal Pharmaceuticals | 0.01% | Hold | 3,319 | $523.47 | $2M | — | — |
| CAPR - Capricor Therapeutics | 0.01% | Hold | 41,000 | $30.40 | $1M | — | — |
| ARWR - Arrowhead Pharmaceuticals | 0.01% | Hold | 15,800 | $62.70 | $991K | — | — |
| GH - Guardant Health | 0.00% | Reduce −92.7% | 8,000 | $92.37 | $739K | −101,000 | −$10M |
| ALKS - Alkermes | 0.00% | Hold | 20,800 | $35.36 | $735K | — | — |
| ALVO - Alvotech | 0.00% | Hold | 199,675 | $3.43 | $685K | — | — |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $169.02 | $676K | — | — |
| COGT - Cogent Biosciences | 0.00% | Hold | 17,000 | $38.49 | $654K | — | — |
| ANNA - Aleanna · CL A | 0.00% | Hold | 78,400 | $8.29 | $650K | — | — |
| ARQT - Arcutis Biotherapeutics | 0.00% | Hold | 26,000 | $23.56 | $613K | — | — |
| CELC - Celcuity | 0.00% | Hold | 4,000 | $114.14 | $457K | — | — |
| LIVN - Livanova | 0.00% | Hold | 6,000 | $63.56 | $381K | — | — |
| TERN - Terns Pharmaceuticals | 0.00% | Reduce −98.9% | 7,000 | $52.72 | $369K | −635,000 | −$26M |
| IONS - Ionis Pharmaceuticals | 0.00% | Hold | 4,800 | $75.09 | $360K | — | — |
| TVTX - Travere Therapeutics | 0.00% | Hold | 12,000 | $29.71 | $357K | — | — |
| GMED - Globus Med · CL A | 0.00% | Hold | 4,000 | $86.16 | $345K | — | — |
| SRRK - Scholar Rock | 0.00% | Hold | 7,000 | $49.16 | $344K | — | — |
| ONC - Beone Medicines | 0.00% | Hold | 1,100 | $296.97 | $327K | — | — |
| WGS - Genedx · CL A | 0.00% | Reduce −92.9% | 5,000 | $64.22 | $321K | −65,000 | −$9M |
| COR - Cencora | 0.00% | Hold | 1,000 | $314.14 | $314K | — | — |
| NUVL - Nuvalent | 0.00% | Hold | 3,000 | $102.45 | $307K | — | — |
| PGNY - Progyny | 0.00% | Hold | 18,000 | $16.98 | $306K | — | — |
| STOK - Stoke Therapeutics | 0.00% | Hold | 9,000 | $32.56 | $293K | — | — |
| EHC - Encompass Health | 0.00% | Reduce −98.7% | 3,000 | $96.73 | $290K | −231,500 | −$25M |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $107.66 | $280K | — | — |
| MIRM - Mirum Pharmaceuticals | 0.00% | Hold | 3,000 | $92.38 | $277K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $19.23 | $269K | — | — |
| KRYS - Krystal Biotech | 0.00% | Reduce −50.0% | 1,000 | $258.32 | $258K | −1,000 | −$235K |
| OMER - Omeros | 0.00% | Hold | 23,000 | $10.56 | $243K | — | — |
| HQY - Healthequity | 0.00% | Reduce −44.0% | 2,800 | $83.57 | $234K | −2,200 | −$224K |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $23.36 | $234K | — | — |
| AM6 - Amicus Therapeutic | 0.00% | Hold | 16,000 | $14.46 | $231K | — | — |
| QURE - Uniqure | 0.00% | Hold | 14,000 | $16.35 | $229K | — | — |
| BCRX - Biocryst Pharmaceuticals | 0.00% | Hold | 24,000 | $9.52 | $228K | — | — |
| VCYT - Veracyte | 0.00% | Hold | 7,000 | $32.21 | $225K | — | — |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $8.02 | $225K | — | — |
| ABVX - Abivax SA | 0.00% | Reduce −99.5% | 2,000 | $111.35 | $223K | −385,000 | −$52M |
| GEHC - GE HealthCare | 0.00% | Hold | 3,000 | $71.18 | $214K | — | — |
| HIMS - Hims & Hers Health · CL A | 0.00% | Reduce −99.7% | 10,000 | $20.76 | $208K | −3,376,986 | −$110M |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $68.93 | $207K | — | — |
| HR - Healthcare Rlty Tr · CL A | 0.00% | Hold | 12,000 | $16.99 | $204K | — | — |
| URGN - Urogen Pharma | 0.00% | Hold | 11,000 | $17.98 | $198K | — | — |
| PGEN - Precigen | 0.00% | Hold | 50,000 | $3.87 | $194K | — | — |
| SDGR - Schrodinger | 0.00% | Reduce −76.1% | 17,000 | $11.36 | $193K | −54,000 | −$1M |
| DYN - Dyne Therapeutics | 0.00% | Hold | 10,000 | $18.13 | $181K | — | — |
| NVAX - Novavax | 0.00% | Reduce −88.7% | 22,000 | $8.14 | $179K | −173,000 | −$1M |
| PACB — | 0.00% | Hold | 135,000 | $1.32 | $178K | — | — |
| ADPT — | 0.00% | Hold | 11,000 | $13.88 | $153K | — | — |
| OCUL - Ocular Therapeutix | 0.00% | Hold | 18,000 | $8.47 | $152K | — | — |
| NEO - Neogenomics | 0.00% | Hold | 19,000 | $7.42 | $141K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $5.99 | $138K | — | — |
| OSCR - Oscar Health · CL A | 0.00% | Reduce −95.8% | 11,000 | $11.47 | $126K | −253,000 | −$4M |
| NUVB - Nuvation Bio · CL A | 0.00% | Hold | 29,000 | $4.29 | $124K | — | — |
| IOVA - Iovance Biotherapeutics | 0.00% | Hold | 26,000 | $3.51 | $91K | — | — |
| ALT - Altimmune | 0.00% | Hold | 27,600 | $3.08 | $85K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $2.63 | $74K | — | — |
| TVRD - Tvardi Therapeutics | 0.00% | Reduce −50.4% | 21,438 | $3.18 | $68K | −21,787 | −$118K |
| GERN - Geron | 0.00% | Hold | 43,000 | $1.49 | $64K | — | — |
| RANI - Rani Therapeutics · CL A | 0.00% | Hold | 78,000 | $0.7348 | $57K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $3.51 | $46K | — | — |
| EVH - Evolent Health · CL A | 0.00% | Hold | 14,000 | $2.28 | $32K | — | — |
| CGC - Canopy Growth | 0.00% | Hold | 30,000 | $0.9492 | $28K | — | — |
| BYND - Beyond Meat | 0.00% | Hold | 19,000 | $0.7016 | $13K | — | — |
Showing top 50 of 154 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| Cyberark Software | 2.22% | Exit | 0 | $446.06 | $470M | −1,053,040 | −$470M |
| CRM - Salesforce | 1.58% | Exit | 0 | $264.91 | $334M | −1,261,177 | −$334M |
| NDAQ - Nasdaq | 1.37% | Exit | 0 | $97.13 | $290M | −2,989,213 | −$290M |
| NYT - New York Times · CL A | 1.07% | Exit | 0 | $69.42 | $228M | −3,280,678 | −$228M |
| DAY - Dayforce | 0.95% | Exit | 0 | $69.16 | $202M | −2,925,000 | −$202M |
| CBRE - CBRE Group · CL A | 0.75% | Exit | 0 | $160.79 | $158M | −983,771 | −$158M |
| GBTC - Ishares Bitcoin Trust ETF | 0.50% | Exit | 0 | $49.65 | $106M | −2,137,100 | −$106M |
| CDTX - Cidara Therapeutics | 0.40% | Exit | 0 | $220.89 | $85M | −382,800 | −$85M |
| TRU - Transunion | 0.27% | Exit | 0 | $85.75 | $58M | −675,000 | −$58M |
| ETHA - Ishares Ethereum Tr | 0.16% | Exit | 0 | $22.43 | $33M | −1,481,001 | −$33M |
| GPCR - Structure Therapeutics | 0.15% | Exit | 0 | $69.55 | $32M | −454,000 | −$32M |
| MLYS - Mineralys Therapeutics | 0.14% | Exit | 0 | $36.29 | $30M | −823,296 | −$30M |
| SUN - Sunococorp | 0.14% | Exit | 0 | $49.28 | $30M | −606,277 | −$30M |
| VSTM - Verastem | 0.07% | Exit | 0 | $7.72 | $15M | −2,000,000 | −$15M |
| DOCS - Doximity · CL A | 0.06% | Exit | 0 | $44.28 | $14M | −311,000 | −$14M |
| MDLN - Medline · CL A | 0.05% | Exit | 0 | $42.00 | $11M | −260,000 | −$11M |
| EDU — | 0.05% | Exit | 0 | $55.03 | $11M | −196,000 | −$11M |
| ETH — | 0.03% | Exit | 0 | $28.06 | $6M | −228,340 | −$6M |
| INSM - Insmed | — | Exit | 0 | $174.00 | $522K | −3,000 | −$522K |
| ASND - Ascendis Pharma A/S | — | Exit | 0 | $213.57 | $299K | −1,400 | −$299K |
| ACLXGBX - Arcellx | — | Exit | 0 | $65.25 | $261K | −4,000 | −$261K |
| SLNOEUR - Soleno Therapeutics | — | Exit | 0 | $46.40 | $232K | −5,000 | −$232K |
| ESTA - Establishment Labs | — | Exit | 0 | $73.00 | $219K | −3,000 | −$219K |
| ICLR - ICON | — | Exit | 0 | $182.50 | $219K | −1,200 | −$219K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2